<?xml version='1.0' encoding='utf-8'?>
<document id="29241088"><sentence text="Development of an LC-MS method to quantify coproporphyrin I and III as endogenous biomarkers for drug transporter-mediated drug-drug interactions." /><sentence text="Coproporphyrins are proposed as endogenous biomarkers of hepatic Organic Anion Transporting Polypeptide (OATP)1B functional activity"><entity charOffset="0-15" id="DDI-PubMed.29241088.s2.e0" text="Coproporphyrins" /></sentence><sentence text=" In this study, a new sample extraction method based on a mixed-mode anion exchange sorbent (SPE clean-up using Oasis 30mg Max 96 well plates) was developed for absolute quantification of coproporphyrin I and III (CP-I and CP-III) in human plasma"><entity charOffset="188-204" id="DDI-PubMed.29241088.s3.e0" text="coproporphyrin I" /></sentence><sentence text=" Chromatographic separation was performed with an Ace Excel 2 C18 PFP, 3μm, 2" /><sentence text="1×150mm, maintained at 60°C" /><sentence text=" A 10mM ammonium formate containing 0"><entity charOffset="8-24" id="DDI-PubMed.29241088.s6.e0" text="ammonium formate" /></sentence><sentence text="1% HCOOH and acetonitrile (100%) was used as mobile phase A and B, respectively"><entity charOffset="3-8" id="DDI-PubMed.29241088.s7.e0" text="HCOOH" /><entity charOffset="13-25" id="DDI-PubMed.29241088.s7.e1" text="acetonitrile" /><pair ddi="false" e1="DDI-PubMed.29241088.s7.e0" e2="DDI-PubMed.29241088.s7.e0" /><pair ddi="false" e1="DDI-PubMed.29241088.s7.e0" e2="DDI-PubMed.29241088.s7.e1" /></sentence><sentence text=" Mass transition, m/z 655" /><sentence text="3→596" /><sentence text="3 was selected to monitor CP-I and CP-III, while m/z 659" /><sentence text="3→600" /><sentence text="3 transition was used for the stable isotope labelled internal standard" /><sentence text=" Optimization of the liquid chromatography tandem mass spectrometry method ensured a lower limit of quantification (LLOQ) of 20pg/mL" /><sentence text=" Both CP-I and CP-III had extraction recoveries of 70%" /><sentence text=" The calibration range was 0" /><sentence text="02-100ng/mL for both CP-I and CP-III, yielding calibration curves with correlation coefficients greater than 0" /><sentence text="988" /><sentence text=" Inter day precision (CV&lt;9%) and accuracy (84" /><sentence text="3-103" /><sentence text="9%) complied with the recommendation of the European Bioanalytical Forum" /><sentence text=" The optimized method was used to analyse plasma samples originating from three independent clinical studies" /><sentence text=" Obtained CP-I and CP-III plasma baseline levels in healthy volunteers were in good agreement with previously published data" /><sentence text=" Moreover, CP-I and CP-III plasma levels in human subjects dosed with a clinically confirmed OATP inhibitor were significantly increased compared to their baseline levels" /><sentence text=" These data demonstrate the potential of CP-I and CP-III as endogenous biomarkers to predict the drug-drug interaction (DDI) related to hepatic OATP1B inhibition" /><sentence text=" Stability of CP-I and CP-III in plasma and solvents under different processing and storage conditions was also evaluated" /><sentence text="" /></document>